SCHEMBL6355846

SCHEMBL6355846

O=C1CSC=C(c2ccccc2)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.37
PTGS2 P35354 1/20 0.37
ADAMTS5 Q9UNA0 5/20 0.36
HPGD P15428 3/20 0.36
USP2 O75604 2/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
AXL P30530 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 4/20 0.34
TDP2 O95551 1/20 0.34
LMNA P02545 1/20 0.34
CFTR P13569 1/20 0.33
GOPC Q9HD26 1/20 0.33
CHEK1 O14757 1/20 0.33
AURKA O14965 1/20 0.33
DAPK3 O43293 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33
ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348411 0.81 ALDH1A1 (0.38) HPGDUSP2HTTTDP1ALDH1A1
SCHEMBL14065284 0.71 AXL (0.39) HPGDHTTAXLSMN1; SMN2ALDH1A1
Biphenyl SCHEMBL3790238 0.68 GSK3A (0.67) ALOX15PTGS2ADAMTS5HPGDUSP2
SCHEMBL11206713 0.68 DDB1 (0.41) HPGDAXLSMN1; SMN2ALDH1A1TDP2
SCHEMBL9277538 0.65 BACE1 (0.40) HPGDHTTAXLSMN1; SMN2ALDH1A1
SCHEMBL10367298 0.64
Biphenyl SCHEMBL7154019 0.63 CRBN (0.58) HPGDHTTAXLSMN1; SMN2ALDH1A1
SCHEMBL6359025 0.60
SCHEMBL7267281 0.60 AXL (0.37) HPGDUSP2HTTTDP1AXL
SCHEMBL10082608 0.60 AHR (0.50) SMN1; SMN2ALDH1A1PDGFRALTKCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2275869-A None JP disclosed
US-6960575-B2 For use as inhibitors of chymase SANTEN PHARMACEUTICAL CO., LTD. (JP) 2005-11-01 US disclosed
US-20040097496-A1 Novel thiazine derivatives SANTEN PHARMACEUTICAL CO.,LTD. (JP) 2004-05-20 US disclosed
US-6713472-B1 2-OXO-1,2,3,4-TETRAHYDROPYRAZINE DERIVATIVES; CHYMASE INHIBITORS SANTEN PHARMACEUTICAL CO., LTD. (JP) 2004-03-30 US disclosed
US-20030212116-A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horitcultural use NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-13 US disclosed
EP-1243580-A1 HETEROCYCLIC IMINO COMPOUNDS AND FUNGICIDES AND INSECTICIDES FOR AGRICULTURAL AND HORTICULTURAL USE Nissan Chemical Industries, Ltd. (JP) 2002-09-25 EP disclosed
EP-1211249-A1 NOVEL THIAZINE OR PYRAZINE DERIVATIVES SANTEN PHARMACEUTICAL CO., LTD. (JP) 2002-06-05 EP disclosed
JP-H02275869-A 1,4-THIAZINE DERIVATIVE TAKEDA CHEM IND LTD 1990-11-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097496-A1 Novel thiazine derivatives CMA1, TPSD1, HRH4 ALOX15 4077/4885PTGS2 2689/4885ADAMTS5 541/4885
US-20030212116-A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horitcultural use DDT, CBR3, CYP1B1 ALOX15 2320/4885PTGS2 1514/4885ADAMTS5 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.